text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 73232-52-7 | Product Number: M3504

Methylnaltrexone Bromide


Purity: >95.0%(HPLC)(qNMR)
Synonyms:
  • 17-(Cyclopropylmethyl)-3,14-dihydroxy-17-methyl-6-oxo-5α-4,5-epoxymorphinan-17-ium Bromide
Product Documents:
10MG
¥23,000
15   It can be shipped from Saitama warehouse on the same day* It can be shipped in about 3-4 weeks after ordering
* Available Stock: Prompt shipment (for products) in Saitama/Hyogo warehouse. Stock In Other WH: Shipment in about 2-3 Business Days from Saitama warehouse. Please contact us if you need further information.
* The displayed price is the unit price and does not include consumption tax. The unit prices displayed are the latest and are subject to change without notice.
* To send your quote request for bulk quantities, please click on the "Request Bulk Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.

Product Number M3504
Purity / Analysis Method >95.0%(HPLC)(qNMR)
Molecular Formula / Molecular Weight C__2__1H__2__6BrNO__4 = 436.35 
Physical State (20 deg.C) Solid
Storage Temperature Frozen (-20°C)
Store Under Inert Gas Store under inert gas
Condition to Avoid Air Sensitive,Hygroscopic,Heat Sensitive
CAS RN 73232-52-7
Reaxys Registry Number 8181088
Specifications
Appearance White to Light yellow powder to crystal
Purity(HPLC) min. 95.0 area%
Purity(qNMR) min. 95.0 %
NMR confirm to structure
Properties (reference)
GHS
Related Laws:
Transport Information:
Application
Methylnaltrexone Bromide: A Selective μ-Opioid Receptor Antagonist

Methylnaltrexone bromide is a selective antagonist of opioid binding at the μ-opioid receptor, a quaternary derivative of naltrexone [N1176]. As a quaternary amine, methylnaltrexone bromide has greater polarity and lower lipid solubility; therefore, it does not cross the blood-brain barrier.1,2) This allows methylnaltrexone bromide to act as a peripherally-acting μ-opioid receptor antagonist in tissues such as the gastrointestinal tract, thereby reducing the constipating effects of opioids without interfering with opioid-mediated analgesic effects on the central nervous system.3) (The product is for research purpose only.)

References


Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.

The requested SDS is not available.

Please Contact Us for more information.

Specifications
C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The product with the lot number searched for has been discontinued and no related documentation is available.

Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.

A sample C of A for this product is not available at this time.

Analytical Charts
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The requested analytical chart is not available. Sorry for the inconvenience.

The product with the lot number searched for has been discontinued and no related documentation is available.

Other Documents

Session Status
Your session will timeout in 10 minutes. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page. minute. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page.

Your session has timed out. You will be redirected to the HOME page.